Independent Director of Devyser Diagnostics Fredrik Dahl Buys 78% More Shares

Even if it's not a huge purchase, we think it was good to see that Fredrik Dahl, the Independent Director of Devyser Diagnostics AB (publ) (STO:DVYSR) recently shelled out kr1.1m to buy stock, at kr72.90 per share. Even though that isn't a massive buy, it did increase their holding by 78%, which is arguably a good sign.

Check out our latest analysis for Devyser Diagnostics

Devyser Diagnostics Insider Transactions Over The Last Year

In fact, the recent purchase by Fredrik Dahl was the biggest purchase of Devyser Diagnostics shares made by an insider individual in the last twelve months, according to our records. That means that an insider was happy to buy shares at around the current price of kr73.00. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. If someone buys shares at well below current prices, it's a good sign on balance, but keep in mind they may no longer see value. Happily, the Devyser Diagnostics insiders decided to buy shares at close to current prices.

While Devyser Diagnostics insiders bought shares during the last year, they didn't sell. The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

There are always plenty of stocks that insiders are buying. So if that suits your style you could check each stock one by one or you could take a look at this free list of companies. (Hint: insiders have been buying them).

Insider Ownership

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. I reckon it's a good sign if insiders own a significant number of shares in the company. Devyser Diagnostics insiders own about kr481m worth of shares (which is 41% of the company). This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.

What Might The Insider Transactions At Devyser Diagnostics Tell Us?

It is good to see recent purchasing. We also take confidence from the longer term picture of insider transactions. But on the other hand, the company made a loss during the last year, which makes us a little cautious. Once you factor in the high insider ownership, it certainly seems like insiders are positive about Devyser Diagnostics. One for the watchlist, at least! In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Devyser Diagnostics. At Simply Wall St, we found 1 warning sign for Devyser Diagnostics that deserve your attention before buying any shares.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.